Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Kolchinsky Peter
Relationship:   Director, 10% Owner
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   21    
Direct Shares   6,648,738    

Indirect Shares

  89,615,900      
Direct Value   $30,628,641    

Indirect Value

  $946,611,696      
Total Shares   96,264,638      
Total Value   $977,240,337      


Achillion Pharmaceuticals Inc
 $29,670,022 Sangamo Biosciences Inc
 $958,619 Forma Therapeutics Holdings, Inc.,
 $0 Achillion Pharmaceuticals Inc
 $29,670,022 Sangamo Biosciences Inc
 $958,619 Forma Therapeutics Holdings, Inc.,
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    1   
    0    

     Stock price went up :

    1   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   0.0   
     Percentage Gain/Loss :
   14.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Aradigm Corp ARDM 10% Owner 2007-03-01 0 2008-01-15 7,681,410    Premium*  
            Curis Inc CRIS 10% Owner 2008-04-15 0 2008-04-15 6,250,564    Premium*  
            Sequenom Inc SQNM 10% Owner 0 2008-06-06 4,617,766    Premium*  
            Biospecifics Technologies Corp BSTC 10% Owner 2008-12-29 0 2009-04-14 825,844    Premium*  
            Lipid Sciences Inc LIPD 10% Owner 2008-03-27 0 2008-03-27 3,705,312    Premium*  
            Achillion Pharmaceuticals Inc ACHN 10% Owner 2013-09-30 4,816,562 2014-09-11 13,000,000    Premium*  
            Sangamo Biosciences Inc SGMO Former 10% Owner 2014-08-01 1,829,426 2013-07-17 0    Premium*  
            Aclaris Therapeutics, Inc. ACRS 10% Owner 2015-10-07 0 2015-10-21 2,314,942    Premium*  
            Ra Pharmaceuticals, Inc. RARX Director, 10% Owner 2016-10-31 0 2020-04-02 0    Premium*  
            Kalvista Pharmaceuticals Inc KALV Director, 10% Owner 2016-11-21 0 2017-10-12 1,441,070    Premium*  
            G1 Therapeutics Inc GTHX Fmr 10% Owner See Foot... 2017-05-22 0 2017-05-22 2,684,244    Premium*  
            Kala Pharmaceuticals, Inc. KALA Director, 10% Owner 2017-07-25 0 2020-03-13 10,874,613    Premium*  
            Wave Life Sciences Ltd. WVE Director, 10% Owner 2017-11-13 0 2019-01-24 7,775,207    Premium*  
            Dicerna Pharmaceuticals Inc DRNA Director 2017-12-18 0 2019-12-02 0    Premium*  
            Eidos Therapeutics, Inc. EIDX 10% Owner 2018-06-22 0 2018-06-22 2,162,671    Premium*  
            Arvinas Holding Company, Llc ARVN Former 10% Owner 2018-10-01 0 2018-10-01 3,138,412    Premium*  
            Synthorx, Inc. THOR Director, 10% Owner 2018-12-11 0 2020-01-23 0    Premium*  
            Satsuma Pharmaceuticals, Inc. STSA Former 10% Owner 2019-09-17 0 2023-06-08 0    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM 10% Owner 0 2019-10-16 5,422,312    Premium*  
            Forma Therapeutics Holdings, Inc., FMTX Director, 10% Owner 2021-06-17 2,750 2021-06-17 9,011,651    Premium*  
            Solid Biosciences Inc SLDB Director, 10% Owner 0 2020-12-10 8,709,882    Premium*  
* Premium Members only  

Records found :    207         Free Registration Required For Full Results.    Limit: 25

Download
  Page 6 of 9
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2018-11-06 4 D $13.84 $3,644,967 I/I (263,300) 2,814,589 0 -
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2018-10-30 4 D $13.86 $3,465,075 I/I (250,000) 3,683,489 0 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-04-17 4 B $14.02 $581,959 D/D 41,500 4,762,078 2.44 -
ACRS Aclaris Therapeutics, Inc... 10% Owner   –       –       •   2015-10-14 4 B $14.06 $601,792 I/I 42,813 2,279,943 1.5 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-06-06 4 S $14.07 $1,930,949 D/D (135,101) 2,579,238 0 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-04-16 4 S $14.09 $307,658 D/D (21,829) 4,720,578 0 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-06-05 4 S $14.13 $1,626,669 D/D (115,102) 2,714,339 0 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-04-11 4 B $14.48 $1,694,299 D/D 116,992 4,723,633 2.44 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-04-22 4 S $14.70 $5,243,538 D/D (352,750) 4,409,328 0 -
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2018-11-07 4 D $14.74 $3,685,050 I/I (250,000) 2,564,589 0 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-04-14 4 S $14.78 $45,165 D/D (3,055) 4,720,578 0 -
ACRS Aclaris Therapeutics, Inc... 10% Owner   –       –       •   2015-10-21 4 B $14.83 $45,976 I/I 3,100 2,314,942 1.5 -
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2018-11-08 4 D $14.86 $1,603,680 I/I (107,920) 2,456,669 0 -
ACRS Aclaris Therapeutics, Inc... 10% Owner   –       –       •   2015-10-19 4 B $14.88 $356,049 I/I 23,934 2,303,877 1.5 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-04-10 4 B $14.91 $1,237,339 D/D 83,000 4,610,044 2.44 -
ACRS Aclaris Therapeutics, Inc... 10% Owner   –       –       •   2015-10-20 4 B $14.95 $119,070 I/I 7,965 2,311,842 1.5 -
GTHX G1 Therapeutics Inc Fmr 10% Owner See Footnote (2)   –       –      –    2017-05-22 4 B $15.00 $6,000,000 I/I 400,000 2,684,244 0.01 -
KALA Kala Pharmaceuticals, Inc... former 10% owner   –       –      –    2017-07-25 4 B $15.00 $7,999,995 I/I 533,333 2,113,236 0.01 -
STSA Satsuma Pharmaceuticals, ... 10% Owner   –       –       •   2019-09-17 4 B $15.00 $19,999,995 I/I 1,333,333 4,681,858 1.5 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-04-04 4 B $15.38 $2,753,712 D/D 179,031 4,441,357 2.44 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-04-07 4 B $15.42 $519,310 D/D 33,667 4,475,024 2.44 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-04-08 4 B $15.49 $1,888,274 D/D 121,876 4,596,900 2.44 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-06-09 4 S $15.50 $1,294,159 D/D (83,500) 2,495,738 0 -
RARX Ra Pharmaceuticals, Inc. Director   –       •       •   2018-12-12 4 B $15.50 $15,600,006 I/I 1,006,452 4,858,260 2.25 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-04-10 4 S $15.67 $53,326 D/D (3,403) 4,606,641 0 -

  207  Records found
  1   2   3   4   5   6  7   8   9      
  Page 6 of 9  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed